196 related articles for article (PubMed ID: 31996771)
21. Tumor necrosis factor inhibitor gene expression suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis.
Zhu Z; Stevenson D; Schechter JE; Mircheff AK; Crow RW; Atkinson R; Ritter T; Bose S; Trousdale MD
Cornea; 2003 May; 22(4):343-51. PubMed ID: 12792478
[TBL] [Abstract][Full Text] [Related]
22. Cathepsin S Alters the Expression of Pro-Inflammatory Cytokines and MMP-9, Partially through Protease-Activated Receptor-2, in Human Corneal Epithelial Cells.
Klinngam W; Fu R; Janga SR; Edman MC; Hamm-Alvarez SF
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423938
[TBL] [Abstract][Full Text] [Related]
23. A novel NOD-derived murine model of primary Sjögren's syndrome.
Robinson CP; Yamachika S; Bounous DI; Brayer J; Jonsson R; Holmdahl R; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 1998 Jan; 41(1):150-6. PubMed ID: 9433880
[TBL] [Abstract][Full Text] [Related]
24. Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland.
Wu K; Joffre C; Li X; MacVeigh-Aloni M; Hom M; Hwang J; Ding C; Gregoire S; Bretillon L; Zhong JF; Hamm-Alvarez SF
Exp Eye Res; 2009 Sep; 89(3):319-32. PubMed ID: 19345210
[TBL] [Abstract][Full Text] [Related]
25. Altered fractalkine cleavage potentially promotes local inflammation in NOD salivary gland.
Wildenberg ME; van Helden-Meeuwsen CG; Drexhage HA; Versnel MA
Arthritis Res Ther; 2008; 10(3):R69. PubMed ID: 18565216
[TBL] [Abstract][Full Text] [Related]
26. Cathepsin S is a novel target for age-related dry eye.
Yu Z; Li J; Govindarajan G; Hamm-Alvarez SF; Alam J; Li DQ; de Paiva CS
Exp Eye Res; 2022 Jan; 214():108895. PubMed ID: 34910926
[TBL] [Abstract][Full Text] [Related]
27. Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
Lieberman SM; Kreiger PA; Koretzky GA
Immunology; 2015 Jun; 145(2):232-41. PubMed ID: 25581706
[TBL] [Abstract][Full Text] [Related]
28. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
29. Age-related spontaneous lacrimal keratoconjunctivitis is accompanied by dysfunctional T regulatory cells.
Coursey TG; Bian F; Zaheer M; Pflugfelder SC; Volpe EA; de Paiva CS
Mucosal Immunol; 2017 May; 10(3):743-756. PubMed ID: 27706128
[TBL] [Abstract][Full Text] [Related]
30. A Multivalent ICAM-1 Binding Nanoparticle which Inhibits ICAM-1 and LFA-1 Interaction Represents a New Tool for the Investigation of Autoimmune-Mediated Dry Eye.
Hsueh PY; Ju Y; Vega A; Edman MC; MacKay JA; Hamm-Alvarez SF
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326657
[TBL] [Abstract][Full Text] [Related]
31. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
[TBL] [Abstract][Full Text] [Related]
32. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
[TBL] [Abstract][Full Text] [Related]
33. Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjögren's syndrome.
Chen FY; Lee A; Ge S; Nathan S; Knox SM; McNamara NA
PLoS One; 2017; 12(9):e0184916. PubMed ID: 28926640
[TBL] [Abstract][Full Text] [Related]
34. CCL22-Producing Resident Macrophages Enhance T Cell Response in Sjögren's Syndrome.
Ushio A; Arakaki R; Otsuka K; Yamada A; Tsunematsu T; Kudo Y; Aota K; Azuma M; Ishimaru N
Front Immunol; 2018; 9():2594. PubMed ID: 30467506
[TBL] [Abstract][Full Text] [Related]
35. The role of fractalkine as an accelerating factor on the autoimmune exocrinopathy in mice.
Tsubota K; Nishiyama T; Mishima K; Inoue H; Doi T; Hattori Y; Kodama T; Higuchi A; Hayashi Y; Saito I
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4753-60. PubMed ID: 19407023
[TBL] [Abstract][Full Text] [Related]
36. Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.
Zhou J; Jin JO; Du J; Yu Q
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7831-8. PubMed ID: 26658504
[TBL] [Abstract][Full Text] [Related]
37. Early Dry Eye Disease Onset in a NOD.H-2h4 Mouse Model of Sjögren's Syndrome.
Li L; Jasmer KJ; Camden JM; Woods LT; Martin AL; Yang Y; Layton M; Petris MJ; Baker OJ; Weisman GA; Petris CK
Invest Ophthalmol Vis Sci; 2022 Jun; 63(6):18. PubMed ID: 35727180
[TBL] [Abstract][Full Text] [Related]
38. Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjögren's syndrome-like exocrinopathy.
Schenke-Layland K; Xie J; Magnusson M; Angelis E; Li X; Wu K; Reinhardt DP; Maclellan WR; Hamm-Alvarez SF
Exp Eye Res; 2010 Feb; 90(2):223-37. PubMed ID: 19852957
[TBL] [Abstract][Full Text] [Related]
39. Critical involvement of macrophage infiltration in the development of Sjögren's syndrome-associated dry eye.
Zhou D; Chen YT; Chen F; Gallup M; Vijmasi T; Bahrami AF; Noble LB; van Rooijen N; McNamara NA
Am J Pathol; 2012 Sep; 181(3):753-60. PubMed ID: 22770665
[TBL] [Abstract][Full Text] [Related]
40. Cathepsin S generates soluble CX3CL1 (fractalkine) in vascular smooth muscle cells.
Fonović UP; Jevnikar Z; Kos J
Biol Chem; 2013 Oct; 394(10):1349-52. PubMed ID: 23893684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
